Pan-cancer analysis of prognostic genes Jordan Anaya Omnes Res, In this study I have used publicly available clinical and.

Slides:



Advertisements
Similar presentations
TOP2A IS AN INDEPENDENT PREDICTOR OF SURVIVAL IN UNSELECTED BREAST CANCER Amit Pancholi Molecular Profiling of Breast Cancer: Predictive Markers of Long.
Advertisements

Original Figures for "Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring"
Departments of Medicine and Biostatistics
Model and Variable Selections for Personalized Medicine Lu Tian (Northwestern University) Hajime Uno (Kitasato University) Tianxi Cai, Els Goetghebeur,
‘Gene Shaving’ as a method for identifying distinct sets of genes with similar expression patterns Tim Randolph & Garth Tan Presentation for Stat 593E.
ICA-based Clustering of Genes from Microarray Expression Data Su-In Lee 1, Serafim Batzoglou 2 1 Department.
Assessment of Lupus (SLE) Mortality in a Patient-Based Community Data Bank Frederick Wolfe 1, Kaleb Michaud 1,2, Tracy Li 3, Robert S. Katz 4 1 National.
Gene expression profiling identifies molecular subtypes of gliomas
A 14-gene prognosis signature predicts metastasis risk in node-negative, estrogen receptor-positive, Tamoxifen-treated breast cancer in different ethnogeographic.
Differential Analysis & FDR Correction
Supplemental Figures Loss of circadian clock gene expression is associated with tumor progression in breast cancer Cristina Cadenas 1*, Leonie van de Sandt.
1.DATABASE construction  n=1,715  Median OS=40.0 months, age: 64+/-10 yrs  Histology (adeno/squamous/large): 50% / 45% / 5%  Stage 1/2/3/4: 63% / 27%
Bioinformatics Brad Windle Ph# Web Site:
Head and Neck Cancer: microRNA analysis
Huidi Liu, M.D. & Ph.D Genomics Research Centre Harbin Medical University, China Reduced expression of SOX7 in ovarian cancer: a novel.
Michael Birrer Ian McNeish New Developments in Biology and Targets of Epithelial Ovarian Cancer.
1 Critical Review of Published Microarray Studies for Cancer Outcome and Guidelines on Statistical Analysis and Reporting Authors: A. Dupuy and R.M. Simon.
Scenario 6 Distinguishing different types of leukemia to target treatment.
Guanylyl Cyclase C (GCC) Lymph Nodes (LN) Classification as a Prognostic Marker in Patients with Stage II Colon Cancer: A Pooled Analysis Daniel J. Sargent,
MBP1010H – Lecture 4: March 26, Multiple regression 2.Survival analysis Reading: Introduction to the Practice of Statistics: Chapters 2, 10 and 11.
MiR-21 can be used as independent prognostic factor for survival and metastasis in urinary bladder cancer. Apostolos Zaravinos 1, Jelena Radojicic 3, George.
Tumor clock protein PER2 as a determinant of survival in patients (pts) receiving oxaliplatin-5-FU- leucovorin as 1st line chemotherapy for metastatic.
THE EFFECT OF AGE ON OUTCOME OF SYNOVIAL SARCOMA PATIENTS A DUTCH POPULATION BASED STUDY Myrella Vlenterie, SEJ Kaal, VKY Ho, R Vlenterie, WTA van der.
Cmab might have therapeutic benefit in Japanese patients with KRAS p.G13D mutant colorectal cancer. Limitations of this study are its retrospective design.
A comparative study of survival models for breast cancer prognostication based on microarray data: a single gene beat them all? B. Haibe-Kains, C. Desmedt,
Jin MENG Shen FU (DPD 08) Biology 2 - Head/Neck and CNS Tumors
Computational Biology Group. Class prediction of tumor samples Supervised Clustering Detection of Subgroups in a Class.
Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin Hoadley, KA et al. Cell 158(4):
Eigengenes as biological signatures Dr. Habil Zare, PhD PI of Oncinfo Lab Assistant Professor, Department of Computer Science Texas State University 5.
Statistical Analysis for Expression Experiments Heather Adams BeeSpace Doctoral Forum Thursday May 21, 2009.
Guide to OncoLnc: A new TCGA data portal
IDENTIFYING CANCER SUBTYPES BASED ON SOMATIC MUTATION PROFILE BIOINFORMATICS SEMINAR 2016 SPRING YOUJIN SHIN.
Mamounas EP et al. Proc SABCS 2012;Abstract S1-10.
miRNA-targets cross-talks: key players in glioblastoma multiforme
Gene expression.
Hallett, et al., - Supplementary Figure 1
Functional Genomics Analysis Reveals a MYC Signature Associated with a Poor Clinical Prognosis in Liposarcomas  Dat Tran, Kundan Verma, Kristin Ward,
Genes with Bimodal Expression Are Robust Diagnostic Targets that Define Distinct Subtypes of Epithelial Ovarian Cancer with Different Overall Survival 
High-level TNFSF13 predict a good response to post-operative chemotherapy in patients with basal-like breast cancer: A systematic review 林惠鈺1,2 歸家豪1,3.
Strategy Description Discovery Validation Application
ML criticality in clinical outcome across cancer types.
Prognostic significance of DDB2 in ovarian cancer.
Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma  Francesco Gatto, Kyle A. Blum, Seyedeh Shaghayegh.
Consensus of Melanoma Gene Expression Subtypes Converges on Biological Entities  Martin Lauss, Jeremie Nsengimana, Johan Staaf, Julia Newton-Bishop, Göran.
Human triple‐negative breast cancers (TNBC) express WNT10B, show active Wnt signalling and have high proliferation, and WNT10B has clinical relevance and.
Volume 23, Issue 11, Pages (June 2018)
Volume 17, Issue 1, Pages (January 2010)
Class Prediction Based on Gene Expression Data Issues in the Design and Analysis of Microarray Experiments Michael D. Radmacher, Ph.D. Biometric Research.
(A) Hierarchical clustering was performed to identify groups of patients with similar RNASeq expression of 20 genes associated with reduced survivability.
Recurrence-Associated Long Non-coding RNA Signature for Determining the Risk of Recurrence in Patients with Colon Cancer  Meng Zhou, Long Hu, Zicheng.
Patterns of Somatically Acquired Amplifications and Deletions in Apparently Normal Tissues of Ovarian Cancer Patients  Leila Aghili, Jasmine Foo, James.
Published online September 20, 2017 by JAMA Surgery
miR-210 Is a Prognostic Marker in Clear Cell Renal Cell Carcinoma
Volume 5, Issue 1, Pages 1-9 (July 2015)
Differential gene expression in whole blood from SJIA patients and healthy controls. A. Data were normalized in Beadstudio using the "average" method and.
Volume 29, Issue 5, Pages (May 2016)
Overlap between changes in de novo protein synthesis after p53- or miR-34a-induction. Overlap between changes in de novo protein synthesis after p53- or.
Patterns of Somatically Acquired Amplifications and Deletions in Apparently Normal Tissues of Ovarian Cancer Patients  Leila Aghili, Jasmine Foo, James.
Volume 26, Issue 12, Pages e5 (March 2019)
DNMT3A2 signatures are coherently modified in AML.
Correlation of DNMT3A expression and its variants with clinical parameters. Correlation of DNMT3A expression and its variants with clinical parameters.
LATS2-associated gene expression pattern is down-regulated specifically in lumB breast tumors. LATS2-associated gene expression pattern is down-regulated.
Identification of aging-related genes and affected biological processes. Identification of aging-related genes and affected biological processes. (A) Experimental.
Figure 1. Identification of three tumour molecular subtypes in CIT and TCGA cohorts. We used CIT multi-omics data ( Figure 1. Identification of.
PD-L1 expression correlates with T-cell markers and an IFN response signature in human melanomas. PD-L1 expression correlates with T-cell markers and an.
EN1 expression in breast cancer and clinical outcome.
lncRNA HOXA11-AS is overexpressed in gastric cancer tissues.
Global analysis of the chemical–genetic interaction map.
Subtype classification of breast functional screening results.
Characteristic gene expression patterns distinguish LCH cells from other immune cells present in LCH lesions. Characteristic gene expression patterns distinguish.
Presentation transcript:

Pan-cancer analysis of prognostic genes Jordan Anaya Omnes Res, In this study I have used publicly available clinical and RNA-SEQ data from the TCGA to investigate each gene’s correlation with survival for 16 different cancers, which included 6,495 patients. For the measure of correlation I used multivariate Cox regression, with gene expression, grade, sex, and age as the multivariates. To improve performance of the models gene expression was inverse normal transformed. Cancers showed large differences in numbers of significantly correlated genes, which could not be explained by sample size or events. However, even cancers with low signal to noise displayed meaningful expression patterns of protective and harmful genes, and gene set enrichments with MSigDB. The most significant protective and harmful genes were not shared across cancers, but these genes were enriched in gene sets that were shared across certain groups of cancers. These groups of cancers were independently recapitulated by both unsupervised clustering of Cox coefficients for individual genes, and for gene programs. This is the first time comprehensive lists of prognostic genes has been made publicly available, and the first time cancers have been compared using a measure of correlation to survival, which contains more information than expression, including hidden information such as treatment response. While some cancers show a large number of genes with p-values below.05 such as LGG, other cancers such as STAD have a nearly flat distribution of p-values. See Table 1 for more details. Abstract Cancers display a range of p-value distributions Clustering of cancers using gene programs Using established gene programs from Hoadley et al., I found the average normalized Cox coefficient for each cancer across the program. The programs and cancers were then clustered with hierarchical clustering. Overall the same cancers which shared gene sets and clustered together with individual gene Cox coefficients again clustered together. Conclusions RNA-SEQ can find meaningful survival correlations across 16 different cancers Cancers show a wide range in the number of genes that meet a FDR cutoff, which should be used to inform p-values found for individual genes Cancers do not share prognostic genes, but do share gene sets Cancers can be clustered with Cox coefficients of individual genes and gene programs The same groupings of cancers (for example LIHC/LUAD/KIRP and COAD/GBM/LUSC) were found with three independent methods, indicating that using prognostic information to compare cancers can find unappreciated commonalities among cancers. Clustering of cancers using gene Cox coefficients Harmful and protective genes display opposite expression patterns I clustered patients with the 100 most significant prognostic genes and 100 most significant harmful genes. In general, protective genes showed very similar expression patterns across patients, and this same trend was seen for harmful genes. This has important implications for identifying a small gene set to predict patient survival. There are thousands of combinations of genes that would give very similar predictions, making identification of one set of genes of questionable utility. It is important to note that while all the genes for STAD did not pass a FDR cutoff, they still showed meaningful expression patterns. The prognostic genes in any cancer can cluster patients into two statistically different groups These Kaplan Meier plots were made with the clusters from above. Not surprisingly the LGG clusters were highly statistically different. More surprising was finding the clusters from STAD also being highly statistically different, indicating that even the cancers with low signal to noise contain useful biological information. As a result, all cancers were included in future analyses. Overlaps of prognostic genes Characteristics of datasets and patients included in this study Overlaps of gene sets The overlaps of the 100 most significant prognostic genes in each cancer. Using the 250 most significant harmful genes in each cancer, I found the 100 most enriched gene sets with MSigDB. These are the overlaps of those 100 gene sets. Some cancers such as LIHC, LUAD, and KIRP share large numbers of gene sets. Cancers were clustered using normalized Cox coefficients of prognostic genes. In general cancers which shared gene sets clustered together. References Hoadley, K. A. et al. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 158, (2014).